CN101024729A - 响应周围环境变化发生体积膨胀的水凝胶及其生产方法和应用 - Google Patents
响应周围环境变化发生体积膨胀的水凝胶及其生产方法和应用 Download PDFInfo
- Publication number
- CN101024729A CN101024729A CNA2007100077925A CN200710007792A CN101024729A CN 101024729 A CN101024729 A CN 101024729A CN A2007100077925 A CNA2007100077925 A CN A2007100077925A CN 200710007792 A CN200710007792 A CN 200710007792A CN 101024729 A CN101024729 A CN 101024729A
- Authority
- CN
- China
- Prior art keywords
- hydrogel
- functional group
- implant site
- monomer
- hydrogels
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000017 hydrogel Substances 0.000 title claims abstract description 141
- 238000000034 method Methods 0.000 title claims abstract description 30
- 230000004044 response Effects 0.000 title abstract description 10
- 238000004519 manufacturing process Methods 0.000 title abstract description 3
- 239000000178 monomer Substances 0.000 claims abstract description 45
- 239000011148 porous material Substances 0.000 claims abstract description 24
- 230000008859 change Effects 0.000 claims abstract description 10
- 229920000642 polymer Polymers 0.000 claims abstract description 8
- 239000000463 material Substances 0.000 claims description 18
- 239000007943 implant Substances 0.000 claims description 14
- 239000003795 chemical substances by application Substances 0.000 claims description 12
- 238000006116 polymerization reaction Methods 0.000 claims description 11
- 125000000524 functional group Chemical group 0.000 claims description 9
- 230000005595 deprotonation Effects 0.000 claims description 8
- 238000010537 deprotonation reaction Methods 0.000 claims description 8
- 230000005855 radiation Effects 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 4
- 239000007858 starting material Substances 0.000 claims description 2
- 230000005588 protonation Effects 0.000 claims 2
- 239000007788 liquid Substances 0.000 abstract description 16
- 239000011541 reaction mixture Substances 0.000 abstract description 10
- 239000002245 particle Substances 0.000 abstract description 9
- 230000007613 environmental effect Effects 0.000 abstract description 4
- 238000002513 implantation Methods 0.000 abstract description 4
- 239000004971 Cross linker Substances 0.000 abstract description 2
- -1 filaments Substances 0.000 abstract description 2
- 239000008188 pellet Substances 0.000 abstract 1
- 239000003505 polymerization initiator Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 41
- 239000000243 solution Substances 0.000 description 29
- 239000011324 bead Substances 0.000 description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 17
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 14
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 14
- 230000008961 swelling Effects 0.000 description 14
- 239000002904 solvent Substances 0.000 description 12
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 10
- 238000001291 vacuum drying Methods 0.000 description 10
- 238000005406 washing Methods 0.000 description 10
- 239000003999 initiator Substances 0.000 description 9
- 238000002347 injection Methods 0.000 description 9
- 239000007924 injection Substances 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 239000000499 gel Substances 0.000 description 8
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 7
- 210000004204 blood vessel Anatomy 0.000 description 7
- 239000012153 distilled water Substances 0.000 description 7
- 230000020477 pH reduction Effects 0.000 description 7
- 208000005189 Embolism Diseases 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000012634 fragment Substances 0.000 description 6
- 206010002329 Aneurysm Diseases 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 229910052697 platinum Inorganic materials 0.000 description 5
- 230000035945 sensitivity Effects 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 4
- 206010053648 Vascular occlusion Diseases 0.000 description 4
- DPDMMXDBJGCCQC-UHFFFAOYSA-N [Na].[Cl] Chemical compound [Na].[Cl] DPDMMXDBJGCCQC-UHFFFAOYSA-N 0.000 description 4
- 125000003368 amide group Chemical group 0.000 description 4
- 230000005540 biological transmission Effects 0.000 description 4
- 150000001261 hydroxy acids Chemical group 0.000 description 4
- 239000011159 matrix material Substances 0.000 description 4
- 239000012266 salt solution Substances 0.000 description 4
- 208000021331 vascular occlusion disease Diseases 0.000 description 4
- PQUXFUBNSYCQAL-UHFFFAOYSA-N 1-(2,3-difluorophenyl)ethanone Chemical compound CC(=O)C1=CC=CC(F)=C1F PQUXFUBNSYCQAL-UHFFFAOYSA-N 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 3
- 206010016717 Fistula Diseases 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 3
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 3
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 3
- 238000004132 cross linking Methods 0.000 description 3
- 230000003890 fistula Effects 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 229940047670 sodium acrylate Drugs 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 101100518972 Caenorhabditis elegans pat-6 gene Proteins 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 210000003484 anatomy Anatomy 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 238000012377 drug delivery Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 229920001477 hydrophilic polymer Polymers 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 125000005395 methacrylic acid group Chemical group 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000004160 Ammonium persulphate Substances 0.000 description 1
- 208000031639 Chromosome Deletion Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical class CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 1
- 102000013275 Somatomedins Human genes 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- JKRWZLOCPLZZEI-UHFFFAOYSA-N alpha-Trichloromethylbenzyl acetate Chemical compound CC(=O)OC(C(Cl)(Cl)Cl)C1=CC=CC=C1 JKRWZLOCPLZZEI-UHFFFAOYSA-N 0.000 description 1
- 235000019395 ammonium persulphate Nutrition 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 210000001188 articular cartilage Anatomy 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 239000000599 controlled substance Substances 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 238000010894 electron beam technology Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000010528 free radical solution polymerization reaction Methods 0.000 description 1
- 239000007863 gel particle Substances 0.000 description 1
- 238000001415 gene therapy Methods 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000000541 pulsatile effect Effects 0.000 description 1
- 230000010349 pulsation Effects 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 230000004043 responsiveness Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000005201 scrubbing Methods 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- IIACRCGMVDHOTQ-UHFFFAOYSA-N sulfamic acid Chemical compound NS(O)(=O)=O IIACRCGMVDHOTQ-UHFFFAOYSA-N 0.000 description 1
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 239000003894 surgical glue Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 229910052715 tantalum Inorganic materials 0.000 description 1
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F22/00—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides or nitriles thereof
- C08F22/36—Amides or imides
- C08F22/38—Amides
- C08F22/385—Monomers containing two or more (meth)acrylamide groups, e.g. N,N'-methylenebisacrylamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
- A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
- A61K49/0457—Semi-solid forms, ointments, gels, hydrogels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/145—Hydrogels or hydrocolloids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Materials For Medical Uses (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Medicinal Preparation (AREA)
- Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/804,935 US6878384B2 (en) | 2001-03-13 | 2001-03-13 | Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use |
| US09/804,935 | 2001-03-13 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB028063848A Division CN1306916C (zh) | 2001-03-13 | 2002-02-28 | 响应周围环境变化发生体积膨胀的水凝胶及其生产方法和应用 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101024729A true CN101024729A (zh) | 2007-08-29 |
Family
ID=25190260
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2007100077925A Pending CN101024729A (zh) | 2001-03-13 | 2002-02-28 | 响应周围环境变化发生体积膨胀的水凝胶及其生产方法和应用 |
| CNB028063848A Expired - Lifetime CN1306916C (zh) | 2001-03-13 | 2002-02-28 | 响应周围环境变化发生体积膨胀的水凝胶及其生产方法和应用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB028063848A Expired - Lifetime CN1306916C (zh) | 2001-03-13 | 2002-02-28 | 响应周围环境变化发生体积膨胀的水凝胶及其生产方法和应用 |
Country Status (9)
| Country | Link |
|---|---|
| US (5) | US6878384B2 (enExample) |
| EP (3) | EP2363104B1 (enExample) |
| JP (2) | JP4416151B2 (enExample) |
| CN (2) | CN101024729A (enExample) |
| AU (3) | AU2002306605B2 (enExample) |
| BR (1) | BRPI0208034B8 (enExample) |
| CA (1) | CA2439925C (enExample) |
| ES (3) | ES2390605T3 (enExample) |
| WO (1) | WO2002071994A1 (enExample) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105555847A (zh) * | 2013-09-19 | 2016-05-04 | 微温森公司 | 聚合物膜 |
| CN106456836A (zh) * | 2014-04-29 | 2017-02-22 | 微温森公司 | 包含活性剂的聚合物 |
| CN107158560A (zh) * | 2017-04-27 | 2017-09-15 | 清华大学 | 基于水凝胶溶胀特性的可控自变形神经微电极 |
| CN111333866A (zh) * | 2020-03-20 | 2020-06-26 | 浙江理工大学 | 一种单层水凝胶、制备方法及用作柔性抓手的应用 |
Families Citing this family (139)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2014200734B2 (en) * | 2001-03-13 | 2015-11-05 | Microvention, Inc. | Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use |
| US6878384B2 (en) | 2001-03-13 | 2005-04-12 | Microvention, Inc. | Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use |
| US20020193813A1 (en) * | 2001-05-04 | 2002-12-19 | Concentric Medical | Hydrogel filament vaso-occlusive device |
| CA2449433A1 (en) * | 2001-06-20 | 2003-01-03 | Microvention, Inc. | Medical devices having full or partial polymer coatings and their methods of manufacture |
| US7572288B2 (en) | 2001-07-20 | 2009-08-11 | Microvention, Inc. | Aneurysm treatment device and method of use |
| US8252040B2 (en) * | 2001-07-20 | 2012-08-28 | Microvention, Inc. | Aneurysm treatment device and method of use |
| JP2005517690A (ja) * | 2002-02-01 | 2005-06-16 | ファイザー・プロダクツ・インク | 固体薬物分散物を含有する即時放出剤形 |
| US8425549B2 (en) | 2002-07-23 | 2013-04-23 | Reverse Medical Corporation | Systems and methods for removing obstructive matter from body lumens and treating vascular defects |
| US7551749B2 (en) | 2002-08-23 | 2009-06-23 | Bose Corporation | Baffle vibration reducing |
| DE10330269A1 (de) * | 2003-07-04 | 2005-01-27 | Instraction Gmbh | System umfassend Effektoren und volumenveränderbare Rezeptoren-modifizierte Elastomere, Verfahren zu ihrer Herstellung und ihrer Verwendung |
| WO2005041987A1 (en) * | 2003-10-29 | 2005-05-12 | Gentis, Inc. | Polymerizable emulsions for tissue engineering |
| US8002830B2 (en) * | 2004-02-06 | 2011-08-23 | Georgia Tech Research Corporation | Surface directed cellular attachment |
| EP1729678A4 (en) * | 2004-02-06 | 2011-08-10 | Georgia Tech Res Inst | BEARING BIOCOMPATIBLE DEVICE |
| US9675476B2 (en) | 2004-05-25 | 2017-06-13 | Covidien Lp | Vascular stenting for aneurysms |
| AU2005247490B2 (en) | 2004-05-25 | 2011-05-19 | Covidien Lp | Flexible vascular occluding device |
| KR101300437B1 (ko) | 2004-05-25 | 2013-08-26 | 코비디엔 엘피 | 동맥류용 혈관 스텐트 |
| JP2008512174A (ja) * | 2004-09-10 | 2008-04-24 | スティッチング ダッチ ポリマー インスティテュート | 放射線不透過性の補綴椎間円板核 |
| US7201918B2 (en) * | 2004-11-16 | 2007-04-10 | Microvention, Inc. | Compositions, systems and methods for treatment of defects in blood vessels |
| US7419486B2 (en) * | 2005-06-15 | 2008-09-02 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Treatment and diagnostic catheters with hydrogel electrodes |
| GB0523999D0 (en) * | 2005-11-25 | 2006-01-04 | Univ Manchester | Microgel particle |
| US7959676B2 (en) * | 2006-02-13 | 2011-06-14 | Lanx, Inc. | Method and apparatus for intervertebral disc support and repair |
| US8152833B2 (en) | 2006-02-22 | 2012-04-10 | Tyco Healthcare Group Lp | Embolic protection systems having radiopaque filter mesh |
| KR101443926B1 (ko) | 2006-06-15 | 2014-10-02 | 마이크로벤션, 인코포레이티드 | 팽창성 중합체로 제조된 색전술용 장치 |
| US8771713B2 (en) | 2007-03-12 | 2014-07-08 | Board Of Regents, The University Of Texas System | Method and process for the production of multi-coated recognitive and releasing systems |
| US9155703B2 (en) | 2007-03-12 | 2015-10-13 | Board Of Regents, The University Of Texas System | Method and process for the production of multi-coated recognitive and releasing systems |
| US8741316B2 (en) * | 2007-03-12 | 2014-06-03 | Board Of Regents, The University Of Texas System | Highly porous, recognitive polymer systems |
| US8821899B2 (en) | 2007-03-12 | 2014-09-02 | Board Of Regents, The University Of Texas System | Method and process for the production of multi-coated recognitive and releasing systems |
| US20110022149A1 (en) * | 2007-06-04 | 2011-01-27 | Cox Brian J | Methods and devices for treatment of vascular defects |
| US9023094B2 (en) | 2007-06-25 | 2015-05-05 | Microvention, Inc. | Self-expanding prosthesis |
| WO2009086208A2 (en) * | 2007-12-21 | 2009-07-09 | Microvention, Inc. | Hydrogel filaments for biomedical uses |
| US8668863B2 (en) * | 2008-02-26 | 2014-03-11 | Board Of Regents, The University Of Texas System | Dendritic macroporous hydrogels prepared by crystal templating |
| CN106798586B (zh) | 2008-04-21 | 2020-06-19 | 科维蒂恩有限合伙公司 | 编织球栓塞装置及输送系统 |
| US9597087B2 (en) | 2008-05-02 | 2017-03-21 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
| WO2009140437A1 (en) | 2008-05-13 | 2009-11-19 | Nfocus Neuromedical, Inc. | Braid implant delivery systems |
| US8180076B2 (en) * | 2008-07-31 | 2012-05-15 | Bose Corporation | System and method for reducing baffle vibration |
| EP2172236A1 (en) * | 2008-10-03 | 2010-04-07 | Koninklijke Philips Electronics N.V. | Breast pump system |
| JP2010162063A (ja) * | 2009-01-13 | 2010-07-29 | Japan Health Science Foundation | 塞栓材 |
| JP2012100680A (ja) * | 2009-03-04 | 2012-05-31 | Terumo Corp | 血管内用処置材 |
| JP2010227172A (ja) * | 2009-03-26 | 2010-10-14 | Terumo Corp | 軟組織増大材料 |
| US8757077B2 (en) | 2009-04-30 | 2014-06-24 | Technip France | Spar mooring line sharing method and system |
| US8409269B2 (en) | 2009-12-21 | 2013-04-02 | Covidien Lp | Procedures for vascular occlusion |
| EP2480166B1 (en) * | 2009-09-24 | 2017-11-29 | Microvention, Inc. | Injectable hydrogel filaments for biomedical uses |
| JP5401254B2 (ja) * | 2009-10-13 | 2014-01-29 | 昌典 石原 | 多孔質合成樹脂製造方法および同多孔質合成樹脂製造方法により製造された多孔質合成樹脂材 |
| CA2777171C (en) * | 2009-10-26 | 2017-09-19 | Microvention, Inc. | Embolization device constructed from expansile polymer |
| CA2778639A1 (en) * | 2009-11-05 | 2011-05-12 | Sequent Medical Inc. | Multiple layer filamentary devices or treatment of vascular defects |
| US8337448B2 (en) | 2010-01-29 | 2012-12-25 | Baxter International Inc. | Apparatus for monitoring and controlling peritoneal dialysis |
| ES2671891T3 (es) | 2010-09-10 | 2018-06-11 | Covidien Lp | Dispositivos para el tratamiento de defectos vasculares |
| US8998947B2 (en) | 2010-09-10 | 2015-04-07 | Medina Medical, Inc. | Devices and methods for the treatment of vascular defects |
| US9351859B2 (en) | 2010-12-06 | 2016-05-31 | Covidien Lp | Vascular remodeling device |
| WO2012134990A1 (en) | 2011-03-25 | 2012-10-04 | Tyco Healthcare Group Lp | Vascular remodeling device |
| WO2012145431A2 (en) | 2011-04-18 | 2012-10-26 | Microvention, Inc. | Embolic devices |
| EP2707077B1 (en) | 2011-05-11 | 2017-10-04 | Microvention, Inc. | Device for occluding a lumen |
| WO2012154782A1 (en) | 2011-05-11 | 2012-11-15 | Tyco Healthcare Group Lp | Vascular remodeling device |
| CA2837303C (en) | 2011-05-26 | 2019-08-20 | Cartiva, Inc. | Tapered joint implant and related tools |
| US9060886B2 (en) | 2011-09-29 | 2015-06-23 | Covidien Lp | Vascular remodeling device |
| US9072620B2 (en) | 2011-11-04 | 2015-07-07 | Covidien Lp | Protuberant aneurysm bridging device deployment method |
| US9011480B2 (en) | 2012-01-20 | 2015-04-21 | Covidien Lp | Aneurysm treatment coils |
| WO2013158781A1 (en) | 2012-04-18 | 2013-10-24 | Microvention, Inc. | Embolic devices |
| US9452070B2 (en) | 2012-10-31 | 2016-09-27 | Covidien Lp | Methods and systems for increasing a density of a region of a vascular device |
| WO2014078458A2 (en) | 2012-11-13 | 2014-05-22 | Covidien Lp | Occlusive devices |
| EP2967772A4 (en) | 2013-03-11 | 2016-11-16 | Microvention Inc | IMPLANTABLE DEVICE WITH ADHESIVE PROPERTIES |
| US10076336B2 (en) | 2013-03-15 | 2018-09-18 | Covidien Lp | Delivery and detachment mechanisms for vascular implants |
| EP2967571B1 (en) | 2013-03-15 | 2022-08-31 | Covidien LP | Occlusive device |
| US9078658B2 (en) | 2013-08-16 | 2015-07-14 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
| US9955976B2 (en) | 2013-08-16 | 2018-05-01 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
| US9963556B2 (en) * | 2013-09-18 | 2018-05-08 | Senseonics, Incorporated | Critical point drying of hydrogels in analyte sensors |
| JP6405369B2 (ja) * | 2013-09-19 | 2018-10-17 | テルモ株式会社 | ポリマー粒子 |
| CN105916495B (zh) | 2013-11-08 | 2019-11-12 | 泰尔茂株式会社 | 聚合物颗粒 |
| US9795400B2 (en) | 2013-11-13 | 2017-10-24 | Covidien Lp | Galvanically assisted attachment of medical devices to thrombus |
| JP6456969B2 (ja) * | 2014-02-21 | 2019-01-23 | マサチューセッツ インスティテュート オブ テクノロジー | 膨張顕微鏡法 |
| WO2015134906A1 (en) * | 2014-03-07 | 2015-09-11 | Endologix, Inc. | Forming hydrogels and materials therefor |
| US10124090B2 (en) | 2014-04-03 | 2018-11-13 | Terumo Corporation | Embolic devices |
| US9629635B2 (en) | 2014-04-14 | 2017-04-25 | Sequent Medical, Inc. | Devices for therapeutic vascular procedures |
| US9713475B2 (en) | 2014-04-18 | 2017-07-25 | Covidien Lp | Embolic medical devices |
| WO2015167751A1 (en) | 2014-04-29 | 2015-11-05 | Microvention, Inc. | Polymers |
| JP2017515567A (ja) | 2014-05-12 | 2017-06-15 | トマス，ジェフリー，イー． | 光子活性化ゲルでコーティングされた頭蓋内ステントおよび塞栓コイル |
| KR102264607B1 (ko) | 2014-07-17 | 2021-06-14 | 더 리전트 오브 더 유니버시티 오브 캘리포니아 | 생물의학적 적용을 위한 제어가능한 자기-어닐링 마이크로겔 입자 |
| US9814466B2 (en) | 2014-08-08 | 2017-11-14 | Covidien Lp | Electrolytic and mechanical detachment for implant delivery systems |
| TW201625754A (zh) * | 2014-11-21 | 2016-07-16 | 艾倫塔斯有限公司 | 單一成份、儲存穩定、可硬化之聚矽氧組成物 |
| US9907880B2 (en) | 2015-03-26 | 2018-03-06 | Microvention, Inc. | Particles |
| CA2981061A1 (en) | 2015-03-31 | 2016-10-06 | Cartiva, Inc. | Hydrogel implants with porous materials and methods |
| EP3636226A1 (en) | 2015-03-31 | 2020-04-15 | Cartiva, Inc. | Carpometacarpal (cmc) implants |
| US10526649B2 (en) | 2015-04-14 | 2020-01-07 | Massachusetts Institute Of Technology | Augmenting in situ nucleic acid sequencing of expanded biological samples with in vitro sequence information |
| US10059990B2 (en) | 2015-04-14 | 2018-08-28 | Massachusetts Institute Of Technology | In situ nucleic acid sequencing of expanded biological samples |
| EP3282961A4 (en) | 2015-04-14 | 2018-12-05 | Cartiva, Inc. | Tooling for creating tapered opening in tissue and related methods |
| US11408890B2 (en) | 2015-04-14 | 2022-08-09 | Massachusetts Institute Of Technology | Iterative expansion microscopy |
| WO2016201250A1 (en) | 2015-06-11 | 2016-12-15 | Microvention, Inc. | Expansile device for implantation |
| WO2017023903A1 (en) * | 2015-08-03 | 2017-02-09 | President And Fellows Of Harvard College | Phase-transforming and switchable metamaterials |
| CA2994957A1 (en) | 2015-08-07 | 2017-02-16 | Massachusetts Institute Of Technology | Protein retention expansion microscopy |
| US10364457B2 (en) | 2015-08-07 | 2019-07-30 | Massachusetts Institute Of Technology | Nanoscale imaging of proteins and nucleic acids via expansion microscopy |
| US10314593B2 (en) | 2015-09-23 | 2019-06-11 | Covidien Lp | Occlusive devices |
| US10478194B2 (en) | 2015-09-23 | 2019-11-19 | Covidien Lp | Occlusive devices |
| AU2016353345B2 (en) | 2015-11-12 | 2021-12-23 | University Of Virginia Patent Foundation | Compositions and methods for vas-occlusive contraception and reversal thereof |
| US11931480B2 (en) | 2016-02-16 | 2024-03-19 | The Regents Of The University Of California | Microporous annealed particle gels and methods of use |
| EP3432826B1 (en) | 2016-03-24 | 2024-10-02 | Covidien LP | Thin wall constructions for vascular flow diversion |
| US10828037B2 (en) | 2016-06-27 | 2020-11-10 | Covidien Lp | Electrolytic detachment with fluid electrical connection |
| US10828039B2 (en) | 2016-06-27 | 2020-11-10 | Covidien Lp | Electrolytic detachment for implantable devices |
| US11051822B2 (en) | 2016-06-28 | 2021-07-06 | Covidien Lp | Implant detachment with thermal activation |
| US20180028715A1 (en) | 2016-07-27 | 2018-02-01 | Contraline, Inc. | Carbon-based compositions useful for occlusive medical devices and methods of making and using them |
| US10478195B2 (en) | 2016-08-04 | 2019-11-19 | Covidien Lp | Devices, systems, and methods for the treatment of vascular defects |
| KR102566112B1 (ko) | 2016-09-28 | 2023-08-10 | 테루모 가부시키가이샤 | 중합체 입자 |
| US20180206851A1 (en) * | 2016-10-19 | 2018-07-26 | Daniel E. Walzman | Hydrogel intrasaccular occlusion device |
| US10576099B2 (en) | 2016-10-21 | 2020-03-03 | Covidien Lp | Injectable scaffold for treatment of intracranial aneurysms and related technology |
| EP3562523A4 (en) | 2016-12-29 | 2020-09-30 | Tempo Therapeutics, Inc. | PROCESSES AND SYSTEMS FOR THE TREATMENT OF A MEDICAL IMPLANT SITE |
| US11931928B2 (en) * | 2016-12-29 | 2024-03-19 | Evonik Superabsorber Llc | Continuous strand superabsorbent polymerization |
| WO2018136856A1 (en) | 2017-01-23 | 2018-07-26 | Massachusetts Institute Of Technology | Multiplexed signal amplified fish via splinted ligation amplification and sequencing |
| US11385481B1 (en) | 2017-02-01 | 2022-07-12 | Ram Pattikonda | Advanced dynamic focus eyewear |
| WO2018157048A1 (en) | 2017-02-24 | 2018-08-30 | Massachusetts Institute Of Technology | Methods for examining podocyte foot processes in human renal samples using conventional optical microscopy |
| WO2018157074A1 (en) | 2017-02-24 | 2018-08-30 | Massachusetts Institute Of Technology | Methods for diagnosing neoplastic lesions |
| CN110709110B (zh) * | 2017-04-05 | 2023-05-16 | 赛特博恩医疗有限公司 | 性质改变的植入物 |
| US11180804B2 (en) | 2017-07-25 | 2021-11-23 | Massachusetts Institute Of Technology | In situ ATAC sequencing |
| US10675036B2 (en) | 2017-08-22 | 2020-06-09 | Covidien Lp | Devices, systems, and methods for the treatment of vascular defects |
| JP6620288B2 (ja) * | 2017-10-25 | 2019-12-18 | メディギア・インターナショナル株式会社 | 生体分解性及び生体代謝性の腫瘍封止剤 |
| WO2019156957A1 (en) | 2018-02-06 | 2019-08-15 | Massachusetts Institute Of Technology | Swellable and structurally homogenous hydrogels and methods of use thereof |
| US11065136B2 (en) | 2018-02-08 | 2021-07-20 | Covidien Lp | Vascular expandable devices |
| US11065009B2 (en) | 2018-02-08 | 2021-07-20 | Covidien Lp | Vascular expandable devices |
| WO2020013833A1 (en) | 2018-07-13 | 2020-01-16 | Massachusetts Institute Of Technology | Dimethylacrylamide (dmaa) hydrogel for expansion microscopy (exm) |
| US10912569B2 (en) | 2018-08-22 | 2021-02-09 | Covidien Lp | Aneurysm treatment coils and associated systems and methods of use |
| US10905432B2 (en) | 2018-08-22 | 2021-02-02 | Covidien Lp | Aneurysm treatment coils and associated systems and methods of use |
| US11678887B2 (en) | 2018-12-17 | 2023-06-20 | Covidien Lp | Devices, systems, and methods for the treatment of vascular defects |
| CN111393563B (zh) * | 2019-01-02 | 2023-04-07 | 湖南工业大学 | 一种温敏性水凝胶的制备方法及监测模具 |
| CA3130889A1 (en) | 2019-02-22 | 2020-08-27 | Massachusetts Institute Of Technology | Iterative direct expansion microscopy |
| CN111686310B (zh) * | 2019-03-11 | 2022-03-29 | 国家纳米科学中心 | 一种抗菌导尿管及其制备方法和应用 |
| US11559309B2 (en) | 2019-03-15 | 2023-01-24 | Sequent Medical, Inc. | Filamentary devices for treatment of vascular defects |
| JP7483743B2 (ja) | 2019-03-15 | 2024-05-15 | マイクロベンション インコーポレイテッド | 血管障害の治療のための可撓性継合部を有するフィラメント状デバイス |
| JP7483744B2 (ja) | 2019-03-15 | 2024-05-15 | マイクロベンション インコーポレイテッド | 血管障害の治療のためのフィラメント状デバイス |
| WO2021092619A1 (en) | 2019-11-04 | 2021-05-14 | Covidien Lp | Systems and methods for treating aneurysms |
| US12265004B2 (en) | 2019-11-05 | 2025-04-01 | Massachusetts Institute Of Technology | Membrane probes for expansion microscopy |
| WO2021113505A1 (en) | 2019-12-05 | 2021-06-10 | Massachusetts Institute Of Technology | Method for preparing a specimen for expansion microscopy |
| US20210282789A1 (en) | 2020-03-11 | 2021-09-16 | Microvention, Inc. | Multiple layer devices for treatment of vascular defects |
| WO2021183793A2 (en) | 2020-03-11 | 2021-09-16 | Microvention, Inc. | Devices for treatment of vascular defects |
| US12070220B2 (en) | 2020-03-11 | 2024-08-27 | Microvention, Inc. | Devices having multiple permeable shells for treatment of vascular defects |
| US11931041B2 (en) | 2020-05-12 | 2024-03-19 | Covidien Lp | Devices, systems, and methods for the treatment of vascular defects |
| CN112300413B (zh) * | 2020-12-29 | 2021-04-09 | 北京泰杰伟业科技有限公司 | 一种超细均匀的丙烯酰胺类聚合物水凝胶丝的制备方法及应用 |
| US12364793B2 (en) | 2021-03-16 | 2025-07-22 | Covidien Lp | Injectable biopolymer compositions and associated systems and methods |
| US12351955B2 (en) * | 2021-05-25 | 2025-07-08 | Technische Universitat Dresden | Stimulus-responsive mesh |
| US12446891B2 (en) | 2021-08-30 | 2025-10-21 | Microvention, Inc. | Devices for treatment of vascular defects |
| CN114561237B (zh) * | 2022-04-19 | 2022-10-28 | 中国科学院兰州化学物理研究所 | 一种剪切响应性水基凝胶润滑剂的制备方法 |
| CN115746360B (zh) * | 2022-11-24 | 2023-12-12 | 无锡学院 | 一种间隙可调的柔性表面增强拉曼散射基底及其制备方法和应用 |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6005161A (en) | 1986-01-28 | 1999-12-21 | Thm Biomedical, Inc. | Method and device for reconstruction of articular cartilage |
| US4990138A (en) * | 1989-07-18 | 1991-02-05 | Baxter International Inc. | Catheter apparatus, and compositions useful for producing same |
| US5635482A (en) | 1989-08-14 | 1997-06-03 | The Regents Of The University Of California | Synthetic compounds and compositions with enhanced cell binding |
| ATE131726T1 (de) * | 1989-10-03 | 1996-01-15 | Advanced Polymer Systems Inc | Erodierbare makroporöse hydrogelpartikeln sowie deren herstellung |
| CA2080224A1 (en) | 1990-04-18 | 1991-10-19 | Jindrich Kopecek | Colonic-targeted oral drug-dosage forms based on crosslinked hydrogels containing azobonds and exhibiting ph-dependent swelling |
| US5226902A (en) | 1991-07-30 | 1993-07-13 | University Of Utah | Pulsatile drug delivery device using stimuli sensitive hydrogel |
| US5514379A (en) | 1992-08-07 | 1996-05-07 | The General Hospital Corporation | Hydrogel compositions and methods of use |
| US5447727A (en) * | 1992-10-14 | 1995-09-05 | The Dow Chemical Company | Water-absorbent polymer having improved properties |
| US5554147A (en) | 1994-02-01 | 1996-09-10 | Caphco, Inc. | Compositions and devices for controlled release of active ingredients |
| US5651979A (en) * | 1995-03-30 | 1997-07-29 | Gel Sciences, Inc. | Apparatus and method for delivering a biologically active compound into a biological environment |
| US5750585A (en) | 1995-04-04 | 1998-05-12 | Purdue Research Foundation | Super absorbent hydrogel foams |
| DE69623597T2 (de) | 1995-12-19 | 2003-05-22 | Bracco Research S.A., Carouge | Tricodobenzene-polymere enthaltende zusammensetzungen zur abbildung des gastrointestinaltraktes |
| US5863551A (en) | 1996-10-16 | 1999-01-26 | Organogel Canada Ltee | Implantable polymer hydrogel for therapeutic uses |
| NZ500075A (en) | 1997-04-02 | 2001-03-30 | Purdue Research Foundation | Method for the oral delivery of a protein encapsulated within a hydrogel matrix |
| US6224893B1 (en) * | 1997-04-11 | 2001-05-01 | Massachusetts Institute Of Technology | Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering |
| US6271278B1 (en) * | 1997-05-13 | 2001-08-07 | Purdue Research Foundation | Hydrogel composites and superporous hydrogel composites having fast swelling, high mechanical strength, and superabsorbent properties |
| US5891192A (en) | 1997-05-22 | 1999-04-06 | The Regents Of The University Of California | Ion-implanted protein-coated intralumenal implants |
| US6077880A (en) * | 1997-08-08 | 2000-06-20 | Cordis Corporation | Highly radiopaque polyolefins and method for making the same |
| EP1059943B1 (en) * | 1998-03-06 | 2004-12-01 | Biosepra Medical Inc. | Implantable particles for tissue bulking and the treatment of gastroesophageal reflux disease, urinary incontinence, and skin wrinkles |
| US6165193A (en) * | 1998-07-06 | 2000-12-26 | Microvention, Inc. | Vascular embolization with an expansible implant |
| KR20000012970A (ko) | 1998-08-03 | 2000-03-06 | 김효근 | 썰폰아마이드기를 포함하는 ph 민감성 고분자 및 그의 제조방법 |
| KR20010031078A (ko) * | 1998-08-13 | 2001-04-16 | 다나카 쇼소 | 수팽윤성 가교 중합체 조성물 및 그의 제법 |
| US5952232A (en) | 1998-09-17 | 1999-09-14 | Rothman; James Edward | Expandible microparticle intracellular delivery system |
| US6187024B1 (en) | 1998-11-10 | 2001-02-13 | Target Therapeutics, Inc. | Bioactive coating for vaso-occlusive devices |
| US6245740B1 (en) | 1998-12-23 | 2001-06-12 | Amgen Inc. | Polyol:oil suspensions for the sustained release of proteins |
| US6371904B1 (en) * | 1998-12-24 | 2002-04-16 | Vivant Medical, Inc. | Subcutaneous cavity marking device and method |
| EP1031354A3 (en) | 1999-01-19 | 2003-02-05 | Rohm And Haas Company | Polymeric MRI Contrast agents |
| US6663607B2 (en) | 1999-07-12 | 2003-12-16 | Scimed Life Systems, Inc. | Bioactive aneurysm closure device assembly and kit |
| US7291673B2 (en) | 2000-06-02 | 2007-11-06 | Eidgenossiche Technische Hochschule Zurich | Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds |
| US6506408B1 (en) * | 2000-07-13 | 2003-01-14 | Scimed Life Systems, Inc. | Implantable or insertable therapeutic agent delivery device |
| US6878384B2 (en) * | 2001-03-13 | 2005-04-12 | Microvention, Inc. | Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use |
| ATE516759T1 (de) | 2001-05-29 | 2011-08-15 | Microvention Inc | Verfahren zur herstellung von expandierbaren filamentösen embolisierungsvorrichtungen |
| US20030014075A1 (en) * | 2001-07-16 | 2003-01-16 | Microvention, Inc. | Methods, materials and apparatus for deterring or preventing endoleaks following endovascular graft implanation |
| AU2002359410A1 (en) | 2001-11-16 | 2003-06-10 | Biocure, Inc. | Methods for initiating in situ formation of hydrogels |
| AU2003234159A1 (en) | 2002-04-22 | 2003-11-03 | Purdue Research Foundation | Hydrogels having enhanced elasticity and mechanical strength properties |
| WO2004010878A1 (en) | 2002-07-31 | 2004-02-05 | Microvention, Inc. | Three element coaxial vaso-occlusive device |
| US20050119687A1 (en) | 2003-09-08 | 2005-06-02 | Dacey Ralph G.Jr. | Methods of, and materials for, treating vascular defects with magnetically controllable hydrogels |
| KR101443926B1 (ko) | 2006-06-15 | 2014-10-02 | 마이크로벤션, 인코포레이티드 | 팽창성 중합체로 제조된 색전술용 장치 |
-
2001
- 2001-03-13 US US09/804,935 patent/US6878384B2/en not_active Expired - Lifetime
-
2002
- 2002-02-28 ES ES10188630T patent/ES2390605T3/es not_active Expired - Lifetime
- 2002-02-28 EP EP10188595.2A patent/EP2363104B1/en not_active Expired - Lifetime
- 2002-02-28 CN CNA2007100077925A patent/CN101024729A/zh active Pending
- 2002-02-28 WO PCT/US2002/005988 patent/WO2002071994A1/en not_active Ceased
- 2002-02-28 ES ES10188595T patent/ES2408014T3/es not_active Expired - Lifetime
- 2002-02-28 AU AU2002306605A patent/AU2002306605B2/en not_active Expired
- 2002-02-28 EP EP02750563.5A patent/EP1372553B1/en not_active Expired - Lifetime
- 2002-02-28 EP EP10188630A patent/EP2308431B1/en not_active Expired - Lifetime
- 2002-02-28 BR BRPI0208034A patent/BRPI0208034B8/pt not_active IP Right Cessation
- 2002-02-28 CN CNB028063848A patent/CN1306916C/zh not_active Expired - Lifetime
- 2002-02-28 CA CA2439925A patent/CA2439925C/en not_active Expired - Lifetime
- 2002-02-28 ES ES02750563.5T patent/ES2478992T3/es not_active Expired - Lifetime
- 2002-02-28 JP JP2002570954A patent/JP4416151B2/ja not_active Expired - Lifetime
-
2005
- 2005-03-24 US US11/090,806 patent/US8231890B2/en not_active Expired - Lifetime
-
2007
- 2007-09-07 AU AU2007216682A patent/AU2007216682B2/en not_active Ceased
-
2009
- 2009-09-10 AU AU2009213041A patent/AU2009213041A1/en not_active Abandoned
- 2009-10-01 JP JP2009229839A patent/JP5154529B2/ja not_active Expired - Lifetime
-
2012
- 2012-06-19 US US13/527,485 patent/US8465779B2/en not_active Expired - Fee Related
-
2013
- 2013-05-20 US US13/898,250 patent/US8734834B2/en not_active Expired - Fee Related
-
2014
- 2014-04-16 US US14/254,661 patent/US20140256837A1/en not_active Abandoned
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105555847A (zh) * | 2013-09-19 | 2016-05-04 | 微温森公司 | 聚合物膜 |
| CN105555847B (zh) * | 2013-09-19 | 2018-08-10 | 微仙美国有限公司 | 聚合物膜 |
| CN106456836A (zh) * | 2014-04-29 | 2017-02-22 | 微温森公司 | 包含活性剂的聚合物 |
| CN106456836B (zh) * | 2014-04-29 | 2019-12-06 | 微仙美国有限公司 | 包含活性剂的聚合物 |
| CN107158560A (zh) * | 2017-04-27 | 2017-09-15 | 清华大学 | 基于水凝胶溶胀特性的可控自变形神经微电极 |
| CN111333866A (zh) * | 2020-03-20 | 2020-06-26 | 浙江理工大学 | 一种单层水凝胶、制备方法及用作柔性抓手的应用 |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101024729A (zh) | 响应周围环境变化发生体积膨胀的水凝胶及其生产方法和应用 | |
| US11759547B2 (en) | Polymers | |
| AU2002306605A1 (en) | Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use | |
| JP4989965B2 (ja) | 治療薬デリバリー用ドラッグ放出生分解性繊維 | |
| JP2004512389A (ja) | 多重刺激可逆性ハイドロゲル | |
| JPH11505734A (ja) | 注入可能なヒドロゲル組成物 | |
| CN101056595A (zh) | 用于治疗血管中的缺陷的组合物、系统和方法 | |
| JPH10127754A (ja) | コラーゲンからなる塞栓材 | |
| AU2014200734B2 (en) | Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use | |
| RU2828358C1 (ru) | СПОСОБ ПОЛУЧЕНИЯ ГИДРОГЕЛЯ НА ОСНОВЕ ПОЛИАКРИЛАМИДА, ХИТОЗАНА И ПОЛИОКСОМЕТАЛЛАТА { Мо132} |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20070829 |